These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5052388)

  • 1. A rapid procedure for laboratory control of simultaneous treatment with intravenous heparin and oral anticoagulant.
    Nyman D; Wahlberg P
    Acta Med Scand; 1972; 192(1-2):125-8. PubMed ID: 5052388
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin and monitoring of peroral anticoagulant therapy].
    Bremmelgaard A
    Ugeskr Laeger; 1986 May; 148(21):1275-6. PubMed ID: 3727111
    [No Abstract]   [Full Text] [Related]  

  • 3. [Administration of oral anticoagulants in heparinized patients].
    Blum J; Bondeli C; Grossman E; Müller L; Marbet GA; Duckert F
    Med Welt; 1982 Oct; 33(41):1436-8. PubMed ID: 7154915
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants.
    Garcia D; Barrett YC; Ramacciotti E; Weitz JI
    J Thromb Haemost; 2013 Feb; 11(2):245-52. PubMed ID: 23216682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant therapy for venous thromboembolism unresolved issues and current recommendations.
    Coon WW
    Postgrad Med; 1978 Apr; 63(4):157-64. PubMed ID: 634863
    [No Abstract]   [Full Text] [Related]  

  • 6. Present status of standardization in coagulation assays for control of oral anticoagulation.
    Dati F; Becker U
    Behring Inst Mitt; 1988 Apr; (82):309-24. PubMed ID: 3408455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Permanent anticoagulant therapy and heparin administration in long-term dialysis].
    Froese P
    Klin Wochenschr; 1969 Oct; 47(20):1111-2. PubMed ID: 5381994
    [No Abstract]   [Full Text] [Related]  

  • 8. New oral antithrombotics: a need for laboratory monitoring. For.
    Mismetti P; Laporte S
    J Thromb Haemost; 2010 Apr; 8(4):621-6. PubMed ID: 20102486
    [No Abstract]   [Full Text] [Related]  

  • 9. [Before administering oral anticoagulant therapy with vitamin K antagonists, should heparin be administered, even when therapy is purely of preventive intent without an acute clinical manifestation?].
    Seitz R
    Internist (Berl); 1995 Nov; 36(11):1099-100. PubMed ID: 8543448
    [No Abstract]   [Full Text] [Related]  

  • 10. New oral antithrombotics: a need for laboratory monitoring. Against.
    Bounameaux H; Reber G
    J Thromb Haemost; 2010 Apr; 8(4):627-30. PubMed ID: 20088926
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticoagulant treatment with intravenous administration of heparin. Criteria of establishment of the dosage and rhythm of administration].
    Stoichiţă-Papilian M; Creţescu R
    Stud Cercet Med Interna; 1972; 13(1):53-62. PubMed ID: 5022326
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of thrombosis of veins of the lower extremities.
    Adar R; Salzman EW
    N Engl J Med; 1975 Feb; 292(7):348-50. PubMed ID: 1090840
    [No Abstract]   [Full Text] [Related]  

  • 13. [Individual laboratory control of anticoagulant therapy].
    Spannagl M; Lill H; Trauner A; Schramm W
    Vasa Suppl; 1992; 35():115-6. PubMed ID: 1481011
    [No Abstract]   [Full Text] [Related]  

  • 14. Repeated Oral or Subcutaneous LMWH Has similar Antithrombotic Activity in a Rat Venous Thrombosis Model: Antithrombotic Activity Correlates With Heparin on Endothelium When Orally Administered.
    Hiebert LM
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):264-272. PubMed ID: 27653610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problems in laboratory monitoring of heparin dosage.
    Kitchen S
    Br J Haematol; 2000 Nov; 111(2):397-406. PubMed ID: 11122078
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction.
    Dotan ZA; Mor Y; Leibovitch I; Varon D; Golomb J; Duvdevani M; Ramon J
    J Urol; 2002 Aug; 168(2):610-3; discussion 614. PubMed ID: 12131319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
    Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulant activity of heparin in intravenous fluids.
    Okuno T; Nelson CA
    J Clin Pathol; 1975 Jun; 28(6):494-7. PubMed ID: 1141451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular weight dependence of the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man.
    Lane DA; MacGregor IR; VanRoss M; Cella G; Kakkar VV
    Thromb Res; 1979; 16(5-6):651-62. PubMed ID: 524315
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin in patients with venous thromboembolism and contraindications to oral anticoagulant therapy.
    Monreal M
    Semin Thromb Hemost; 1997; 23(1):69-75. PubMed ID: 9156413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.